Clinical trial
Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and…
NCT00361023 · Shanghai Jiao Tong University School of Medicine, Other · Completed
Key facts
| NCT number | NCT00361023 |
|---|---|
| Title | Effects of Losartan on Insulin Sensitivity and Secretion in Type 2 Diabetes and Nephropathy |
| Official title | Effects of Angiotensin Type 1 Receptor Blockade With Losartan on Insulin Sensitivity and Secretion in Subjects With Type 2 Diabetes and Nephropathy |
| Lead sponsor | Shanghai Jiao Tong University School of Medicine, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Type 2 Diabetes, Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | losartan |
| Enrollment | 25 |
| Start date | Jan 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Aug 7, 2006 |
| Last update posted | Aug 7, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: